Starting 3/9/26, the E-FORCSE reporting system will include an alert for patients that may be experiencing MOUD treatment discontinuation. This alert is provided for informational purposes only and does not confirm prescribing intent or patient risk. For more information about the indicator, please see: https://pmpawarxe.zendesk.com/hc/en-us/articles/40402886110867-MOUD-Clarity